Toxicology and pharmacology of synthetic organoselenium compounds: An update

CW Nogueira, NV Barbosa, JBT Rocha - Archives of Toxicology, 2021 - Springer
Here, we addressed the pharmacology and toxicology of synthetic organoselenium
compounds and some naturally occurring organoselenium amino acids. The use of …

Recent advances in polymer-based vaginal drug delivery systems

T Osmałek, A Froelich, B Jadach, A Tatarek… - Pharmaceutics, 2021 - mdpi.com
The vagina has been considered a potential drug administration route for centuries. Most of
the currently marketed and investigated vaginal formulations are composed with the use of …

Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro

R Vartak, SM Patil, A Saraswat, M Patki, NK Kunda… - …, 2021 - Taylor & Francis
Aim: To formulate an aerosolized nanoliposomal carrier for remdesivir (AL-Rem) against
coronavirus disease 2019. Methods: AL-Rem was prepared using modified hydration …

Cetuximab-based PROteolysis targeting chimera for effectual downregulation of NSCLC with varied EGFR mutations

R Vartak, B Deore, CA Sanhueza, K Patel - International Journal of …, 2023 - Elsevier
Abstract PROteolysis Targeting Chimeras (PROTACs) showed tremendous therapeutic
potential in degrading several oncoproteins including undruggable proteins. PROTACs are …

Implementation of Water‐Soluble Cyclodextrin‐Based Polymers in Biomedical Applications: How Far Are We?

M Agnes, E Pancani, M Malanga… - Macromolecular …, 2022 - Wiley Online Library
Cyclodextrin‐based polymers can be prepared starting from the naturally occurring
monomers following green and low‐cost procedures. They can be selectively derivatized …

Susceptibility of lung carcinoma cells to nanostructured lipid carrier of ARV-825, a BRD4 degrading proteolysis targeting chimera

R Vartak, A Saraswat, Y Yang, ZS Chen… - Pharmaceutical …, 2022 - Springer
The present work was aimed at developing an optimized and modified nanostructured lipid
carrier of BRD4 protein degrading Proteolysis Targeting Chimera (PROTAC) against non …

Soluplus® as a solubilizing excipient for poorly water-soluble drugs: recent advances in formulation strategies and pharmaceutical product features

MS Attia, A Elshahat, A Hamdy, AM Fathi… - Journal of Drug Delivery …, 2023 - Elsevier
Since the emergence of Soluplus®(SOL) as a commercial graft copolymer, several
publications have been issued on its promising potential as a solubilizing excipient that …

Cyclodextrin-based supramolecular ternary complexes: emerging role of ternary agents on drug solubility, stability, and bioavailability

P Suvarna, P Chaudhari… - Critical Reviews™ in …, 2022 - dl.begellhouse.com
The aqueous solubility of active drug moiety plays a crucial role in the development of an
efficacious formulation. The poor aqueous solubility of BCS class II and IV drugs is …

Evaluation of the antifungal activity of an ebselen-loaded nanoemulsion in a mouse model of vulvovaginal candidiasis

S Menon, R Vartak, K Patel, B Billack - … : Nanotechnology, Biology and …, 2021 - Elsevier
Vulvovaginal candidiasis (VVC), caused by Candida albicans, is a common infection in
women affecting their quality of life. Standard antifungal drugs (eg, fluconazole …

Enhancement in the therapeutic potential of lapatinib ditosylate against breast cancer by the use of β-cyclodextrin based ternary nanosponge system

PT Mane, BS Wakure, PS Wakte - International Journal of Pharmaceutics, 2023 - Elsevier
The present investigation was performed to demonstrate the therapeutic potential of
lapatinib ditosylate (LD) loaded nanosponge for the treatment of breast cancer. The study …